The Effect of Weight on Vitamin D Dose Response (Weight)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01013584 |
Recruitment Status :
Completed
First Posted : November 13, 2009
Last Update Posted : June 26, 2012
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Obesity Vitamin D Deficiency | Dietary Supplement: cholecalciferol | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 67 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Participant) |
Primary Purpose: | Treatment |
Official Title: | The Effect of Weight on Vitamin D Dose Response |
Study Start Date : | November 2009 |
Actual Primary Completion Date : | June 2011 |
Actual Study Completion Date : | July 2011 |

Arm | Intervention/treatment |
---|---|
Active Comparator: 1,000 IU
1,000 IU/day of vitamin D3
|
Dietary Supplement: cholecalciferol
daily dose |
Active Comparator: 5,000 IU
5,000 IU/day of vitamin D3
|
Dietary Supplement: cholecalciferol
daily dose |
Active Comparator: 10,000 IU
10,000 IU/day of vitamin D3
|
Dietary Supplement: cholecalciferol
daily dose |
- To characterize the dose response of 25(OH)D to 1,000, 5,000 or 10,000 IU/day of vitamin D3 for 21 weeks in a group of obese men and women. [ Time Frame: 21 weeks ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 19 Years to 60 Years (Adult) |
Sexes Eligible for Study: | Male |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- men aged 19 to 60 with BMI > 30.0.
- They will have low (<1,000 IU) usual intake of vitamin D (from milk, multivitamins, supplements, and fortified foods)
Exclusion Criteria:
- Subjects will not have history of hepatic or renal disease.
- Subjects will not be taking medications known to affect vitamin D metabolism such as anti-seizure medications and/or corticosteroids.
- They will not be on hydrochlorothiazide medications which could cause hypercalcemia.
- They will not have diseases causing malabsorption of vitamin D, such as celiac sprue or small bowel surgeries.
- Pregnancy is also an exclusion criterion.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01013584
United States, Nebraska | |
Creighton University | |
Omaha, Nebraska, United States, 68131 |
Principal Investigator: | Andjela Drincic, MD | Creighton University |
Responsible Party: | Creighton University |
ClinicalTrials.gov Identifier: | NCT01013584 |
Other Study ID Numbers: |
Creighton 8 |
First Posted: | November 13, 2009 Key Record Dates |
Last Update Posted: | June 26, 2012 |
Last Verified: | June 2012 |
vitamin D |
Vitamin D Deficiency Avitaminosis Deficiency Diseases Malnutrition Nutrition Disorders Cholecalciferol |
Vitamin D Calcium-Regulating Hormones and Agents Physiological Effects of Drugs Vitamins Micronutrients Bone Density Conservation Agents |